Resistance to Glomerulosclerosis in B6 Mice Disappears After Menopause

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2003 Mar 26

PMID 12651625

Citations 37

Authors

Feng Zheng

Anna Rita Plati

Mylene Potier

Yvonne Schulman

Mariana Berho

Anita Banerjee

Baudouin LeClercq

Ariel Zisman

Liliane J Striker

Gary E Striker

Affiliations

Soon will be listed here.

Abstract

The frequency of chronic renal failure increases with age, especially in women after menopause. Glomerulosclerosis is a common cause of chronic renal failure in aging. We reported that pre-menopausal female C57BL6 (B6) mice are resistant to glomerulosclerosis, irrespective of the type of injury. However, we now show that B6 mice develop progressive glomerulosclerosis after menopause. Glomerular lesions, first recognized in 18-month-old mice, consisted of hypertrophy, vascular pole sclerosis, and mesangial cell proliferation. Diffuse but moderate mesangial sclerosis and more marked hypertrophy were present at 22 months. At 28 to 30 months the glomerulosclerosis was diffuse and increased levels of type I and type IV collagen and transforming growth factor-beta 1 mRNA were present. Urine albumin excretion was significantly increased in 30-month-old mice. Mesangial cells isolated from 28-month-old mice retained their sclerotic phenotype in vitro. Comparison of the effects of uninephrectomy (Nx) in 20-month-old and 2.5-month-old mice revealed a 1.7-fold increase in urine albumin excretion, accelerated glomerulosclerosis, and renal function insufficiency in 20-month-old Nx mice, but not in 2.5-month-old Nx mice. Glycemic levels, glucose, insulin tolerance, and blood pressure were normal at all ages. Thus, B6 mice model the increased frequency of chronic renal failure in postmenopausal women and provide a model for studying the mechanism(s) of glomerulosclerosis in aging women.

Citing Articles

37 kDa LRP::FLAG enhances telomerase activity and reduces ageing markers in vivo.

Otgaar T, Bernert M, Morris G, Baichan P, Bignoux M, Letsolo B Cell Mol Life Sci. 2025; 82(1):83.

PMID: 39985566 PMC: 11846807. DOI: 10.1007/s00018-025-05593-0.

A Perspective on Evaluating Life Stage Differences in Drug Dosages for Drug Labeling and Instructions.

Gu T, Wang G, van den Oord E, Goldman E, Yang C, Xie N AAPS J. 2024; 26(5):95.

PMID: 39164430 DOI: 10.1208/s12248-024-00964-0.

Gender-Specific Renoprotective Pathways in αMUPA Transgenic Mice Subjected to Acute Kidney Injury.

Alkhaleq H, Hamoud S, Hacker I, Karram T, Fokra A, Kabala A Int J Mol Sci. 2024; 25(6).

PMID: 38542516 PMC: 10971293. DOI: 10.3390/ijms25063544.

The mTOR signaling pathway in cardiac aging.

Dai D, Kang P, Bai H J Cardiovasc Aging. 2023; 3(3).

PMID: 37274127 PMC: 10237620. DOI: 10.20517/jca.2023.10.

The Aging Heart: A Molecular and Clinical Challenge.

Lazzeroni D, Villatore A, Souryal G, Pili G, Peretto G Int J Mol Sci. 2022; 23(24).

PMID: 36555671 PMC: 9783309. DOI: 10.3390/ijms232416033.

References

Schocklmann H, Lang S, Sterzel R . Regulation of mesangial cell proliferation. Kidney Int. 1999; 56(4):1199-207. DOI: 10.1046/j.1523-1755.1999.00710.x. View

Baylis C . Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor. J Clin Invest. 1994; 94(5):1823-9. PMC: 294581. DOI: 10.1172/JCI117531. View

Ma L, Nakamura S, Whitsitt J, Marcantoni C, Davidson J, Fogo A . Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1. Kidney Int. 2000; 58(6):2425-36. DOI: 10.1046/j.1523-1755.2000.00426.x. View

Potier M, Elliot S, Tack I, Lenz O, Striker G, Striker L . Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J Am Soc Nephrol. 2001; 12(2):241-251. DOI: 10.1681/ASN.V122241. View

Coresh J, Wei G, McQuillan G, Brancati F, Levey A, Jones C . Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med. 2001; 161(9):1207-16. DOI: 10.1001/archinte.161.9.1207. View

Poncelet A, Schnaper H . Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells. J Biol Chem. 2000; 276(10):6983-92. DOI: 10.1074/jbc.M006442200. View

Cornacchia F, Fornoni A, Plati A, Thomas A, Wang Y, Inverardi L . Glomerulosclerosis is transmitted by bone marrow-derived mesangial cell progenitors. J Clin Invest. 2001; 108(11):1649-56. PMC: 200982. DOI: 10.1172/JCI12916. View

Fornoni A, Striker L, Zheng F, Striker G . Reversibility of glucose-induced changes in mesangial cell extracellular matrix depends on the genetic background. Diabetes. 2002; 51(2):499-505. DOI: 10.2337/diabetes.51.2.499. View

Zheng F, Fornoni A, Elliot S, Guan Y, Breyer M, Striker L . Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation. Am J Physiol Renal Physiol. 2002; 282(4):F639-48. DOI: 10.1152/ajprenal.00189.2001. View

10.

Potier M, Karl M, Zheng F, Elliot S, Striker G, Striker L . Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens. Am J Pathol. 2002; 160(5):1877-85. PMC: 1850880. DOI: 10.1016/S0002-9440(10)61134-0. View

11.

Striker G, Nagle R, Kohnen P, SMUCKLER E . Response to unilateral nephrectomy in old rats. Arch Pathol. 1969; 87(4):439-42. View

12.

Hackbarth H, Harrison D . Changes with age in renal function and morphology in C57BL/6, CBA/HT6, and B6CBAF1 mice. J Gerontol. 1982; 37(5):540-7. DOI: 10.1093/geronj/37.5.540. View

13.

NELSON J, Felicio L, Randall P, Sims C, Finch C . A longitudinal study of estrous cyclicity in aging C57BL/6J mice: I. Cycle frequency, length and vaginal cytology. Biol Reprod. 1982; 27(2):327-39. DOI: 10.1095/biolreprod27.2.327. View

14.

Anderson S, Brenner B . Effects of aging on the renal glomerulus. Am J Med. 1986; 80(3):435-42. DOI: 10.1016/0002-9343(86)90718-7. View

15.

Davies I, Fotheringham A, Faragher B . Age-associated changes in the kidney of the laboratory mouse. Age Ageing. 1989; 18(2):127-33. DOI: 10.1093/ageing/18.2.127. View

16.

Yumura W, Sugino N, Nagasawa R, Kubo S, Hirokawa K, Maruyama N . Age-associated changes in renal glomeruli of mice. Exp Gerontol. 1989; 24(3):237-49. DOI: 10.1016/0531-5565(89)90015-6. View

17.

MacKay K, Striker L, Stauffer J, Agodoa L, Striker G . Relationship of glomerular hypertrophy and sclerosis: studies in SV40 transgenic mice. Kidney Int. 1990; 37(2):741-8. DOI: 10.1038/ki.1990.41. View

18.

Doi T, Striker L, Gibson C, Agodoa L, Brinster R, Striker G . Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. Am J Pathol. 1990; 137(3):541-52. PMC: 1877515. View

19.

Fogo A, Ichikawa I . Evidence for a pathogenic linkage between glomerular hypertrophy and sclerosis. Am J Kidney Dis. 1991; 17(6):666-9. DOI: 10.1016/s0272-6386(12)80347-7. View

20.

Johnson R, Floege J, Yoshimura A, Iida H, Couser W, Alpers C . The activated mesangial cell: a glomerular "myofibroblast"?. J Am Soc Nephrol. 1992; 2(10 Suppl):S190-7. DOI: 10.1681/ASN.V210s190. View